Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04161768

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Spontaneous Bacterial Peritonitis

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Sherief Abd-Elsalam

Tanta, Egypt

Location status: Recruiting

Location contact

Sherief Abd-Elsalam

CONTACT

About this study

Comparative Study of Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • cirrhotic patients with ascites who had previous episodes of SBP.

Exclusion criteria

  • 1. Allergy or contraindication for the used drugs. 2. Recent antibiotics therapy in the previous 2 weeks. 3. Patients with hepatocellular carcinoma or other neoplasia. 4. Pregnant and lactating women.

Treatment and study plan

Norfloxacin

Drug

Norfloxacin 400 mg daily

Other names: Epinor

Itopride

Drug

Itopride 50 mg three times daily

Other names: Ganaton

Primary outcomes

  1. Number of bouts of recurrence during treatment.

    Time frame: 6 months

    The recurrence of infection during treatment.

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

sherief abd-elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

Comparative Study of Norfloxacin Versus Norfloxacin With Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Important dates

Study start
2018
Primary completion
2028
Study completion
2028
First posted
Nov 13, 2019
Registry last updated
Nov 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.